The loss of function of PTEN enhances resistance to sensitivity and chemotherapeutic of mTOR, which inhibits in breast cancer cells and, afterwards, PTEN exosomal shuttle, could be drew out as a shuttle mechanism or drug resistance changes (Steelman et al., 2008). Here, PTEN is linked to breast cancer.